Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.0B | 2.1B | 2.6B | 2.5B |
Cost of revenue | 157M | 173M | 19M | 20M |
Gross profit | 1.9B | 1.9B | 2.6B | 2.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 98M | 112M | — | — |
Other operating expenses | 650M | 727M | 1.1B | 1.1B |
Operating income | 252M | 139M | 436M | 346M |
Non operating interest income | ||||
Income | 61M | 78M | 89M | 60M |
Expense | 61M | 67M | 55M | 83M |
Other income expense | — | — | — | — |
Pretax income | -2.3B | -348M | 5.1B | 186M |
Tax provision | 25M | -31M | 106M | 65M |
Net income | -2.3B | -260M | 5.1B | 6.7B |
Basic EPS | -9.9 | -1.1 | 21.9 | 29.2 |
Diluted EPS | -9.9 | -1.1 | 21.8 | 29.2 |
Basic average shares | 226.3M | 232.1M | 233.4M | 230.1M |
Diluted average shares | 226.3M | 232.1M | 233.9M | 230.1M |
EBITDA | 468M | 1.8B | 779M | 639M |
Net income from continuing op. | -2.2B | -281M | 5.2B | 6.8B |
Minority interests | 6M | 0 | -1M | -5M |
Preferred stock dividends | 0 | 0 | 0 | 0 |